Altogether, although data on histone modifications in metabolic diseases including NAFLD and key players such as PPARα remain fragmentary, the current data already highlight the importance of histone methylation and acetylation regulation of PPARα in the development of NAFLD. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.